Analysts Offer Insights on Healthcare Companies: Immatics (IMTX), Biogen (BIIB) and Bicycle Therapeutics (BCYC)
September 11 2022 - 02:20AM
TipRanks
Analysts have been eager to weigh in on the Healthcare sector with
new ratings on Immatics (IMTX – Research Report), Biogen (BIIB –
Research Report) and Bicycle Therapeutics (BCYC – Research Report).
Immatics (IMTX) Chardan Capital analyst Geulah Livshits reiterated
a Buy rating on Immatics on September 9 and set a price target of
$28.00. The company's shares closed last Friday at $12.85.
According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immatics-imtx-biogen-biib-and-bicycle-therapeutics-bcyc?utm_source=advfn.com&utm_medium=referral
Immatics NV (NASDAQ:IMTX)
Historical Stock Chart
From Aug 2023 to Sep 2023
Immatics NV (NASDAQ:IMTX)
Historical Stock Chart
From Sep 2022 to Sep 2023
